Stay updated on Boston Scientific Press Releases
Sign up to get notified when there's something new on the Boston Scientific Press Releases page.

Latest updates to the Boston Scientific Press Releases page
- Check4 days agoChange DetectedThe release list now features the Nov. 2, 2026 SIMPLAAFY study, reporting that the WATCHMAN FLX Pro device study met its primary endpoints and that post-implant monotherapies were non-inferior to dual antiplatelet therapy. The earlier April 26 Heart Rhythm 2026 release about FARAPULSE and WATCHMAN data is no longer listed.SummaryDifference2%

- Check11 days agoChange DetectedThe releases list now features Boston Scientific’s third-quarter 2026 results and participation in Stifel’s Healthcare Conference, with a revised excerpt for the October 7 operating-structure announcement. The first-quarter 2026 results and conference-call listings have been removed.SummaryDifference7%

- Check32 days agoChange DetectedA release announcing Joseph M. Fitzgerald’s appointment as Boston Scientific’s Executive Vice President and Chief Operating Officer was added. The listing for the Asurys Fluid Management System’s FDA clearance was removed.SummaryDifference2%

- Check89 days agoChange DetectedAdds new News Releases items announcing Wells Fargo conference participation and a related Q3 2026 conference call (Aug 10, 2026) and removes two older WATCHMAN FLX-related press items from Mar 28, 2026.SummaryDifference2%

- Check103 days agoChange DetectedThe press releases list now includes 'Boston Scientific announces results for second quarter 2026' with the Q2 2026 net sales figure of $5.442 billion dated Jul 29, 2026. Additionally, two older press releases on EKOS/PEITHO and a March 28, 2026 entry were removed.SummaryDifference2%

- Check117 days agoChange DetectedThree new items were added to the News Releases list: late-breaking trial data related to a global pivotal study in patients with severe coronary artery disease. The page also includes updates about a $2 billion accelerated share repurchase program as part of the company’s buyback authorization and an exclusive option to acquire a novel balloon-expandable transcatheter aortic valve made with a proprietary rhenium alloy.SummaryDifference0.6%

Stay in the know with updates to Boston Scientific Press Releases
Enter your email address, and we'll notify you when there's something new on the Boston Scientific Press Releases page.